ABX has received marketing authorisation for the radiotracer Radelumin® in Germany!
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany! This marks the 8th European country in which the authorisation has been obtained. In France, Radelumin® is already in application since December 2022 – production and marketing in the additional seven countries will start by the beginning of 2024.
More information: Press Release Radelumin®